-
Ogilvy names UK influence lead
Ogilvy UK has promoted Imogen Coles to UK influence lead following what the agency called an ‘unprecedented year of growth’ at its influencer specialism.
-
Rachel Friend joins Harvard in new role as leadership trio depart
Rachel Friend, former chief executive of Weber Shandwick UK & Ireland and W Communications, has joined Harvard in the new position of executive chair – as three senior Harvard figures leave to set up their own consultancy.
-
Third City makes senior promotions as joint MD departs
Third City has promoted Kate Mallett to head of fintech and Suzie Barrett to sole managing director, following the departure of joint managing director Chris Blackwood.
-
Heineken adds UK PR agency to roster
Heineken UK has appointed The Romans after a four-way pitch.
-
Charlesbye launches public affairs practice
Charlesbye, the strategic advisory firm founded by former Downing Street comms director Lee Cain, is launching a public affairs practice.
-
Social media guide for pharma firms published
The Prescription Medicines Code of Practice Authority (PMCPA) has published its first guidance for pharma companies on using social media.
-
Women in PR names new president
Jo Carr, co-founder and chief client officer at PR agency Hope&Glory, has been named the new president of Women in PR (WiPR), as incumbent Anna Geffert steps down.
-
Next 15 expects slower growth in H2 but hails ‘strong’ FY
Next 15 expects organic revenue growth to have slowed to 12 per cent in the second half of its financial year, although the group described the full-year performance as ‘strong’ and ‘in line with management expectations’.
-
Ketchum makes key UK and global markets promotions
Ketchum has promoted Sera Holland to the new position of chief strategy and innovation officer, global markets, while Heather Blundell moves to Holland’s former role as UK deputy chief executive.
-
Markettiers4DC sells majority stake in substantial deal
Markettiers4DC has sold a majority stake to private equity firm Waterland in a deal believed to be worth upwards of £50m.
-
One in four women in public affairs plan to quit due to rising costs – survey
One in three women working in public affairs say they have received no additional support to deal with the cost-of-living crisis, and more than one in four plan to leave their job due to rising costs, new research shows.
-
Hotwire launches strategic review of UK workforce
Tech comms agency Hotwire has initiated a strategic review of its workforce in the UK, PRWeek has learned.
-
Ketchum hires UK health chief from Havas
Ketchum has recruited Katy Davidson, formerly deputy managing director at Havas Life Medicom, as health MD for the UK.
-
Teneo to buy Tulchan Communications
Teneo has agreed to buy Tulchan Communications, the London-based financial and corporate specialist.
-
From the UK editor: six things PR (and PRs) should do in 2023
We’ve seen predictions aplenty about our sector in 2023, but what should PR focus on to make the most of the year ahead?
-
12 UK PR agencies to watch in 2023
Which agencies are worth keeping an eye on this year?
-
'Good PR is knowing what to share and what not to' - has Harry damaged his reputation beyond repair?
From fights with his brother to drug use and his frank views on killing people in the army; revelations in Prince Harry's autobiography Spare have shocked and, predictably, caused a media storm.
-
PR agency founder and UN comms stalwart in New Year Honours
Communications agency co-founder and business coach Mavis Amankwah, and former United Nations news and media chief Hua Jiang, are among the industry professionals included in the King's New Year Honours list.
-
Saudi, Danone, Direct Line, Vodafone... 10 account moves that shook up PR in 2022
This year has seen its fair share of major PR account moves. PRWeek UK looks at 10 that stood out.
-
Ex-Downing Street spad among senior hires at TB Cardew
Emma Pascoe-Watson, a former special adviser to Liz Truss as Prime Minister, is among three senior appointments at financial and corporate comms agency TB Cardew.
Recent Articles by John Harrington